World Smoking-Cessation Drug Market 2010-2025

Smoking is a leading cause of preventable death worldwide. In 2009, total sales of smoking-cessation products surpassed $1.6bn (Rx products). The effects of smoking constitute a major burden on public healthcare systems, as well as lowering quality of life for many people. Currently-marketed smoking-cessation products arguably lack the desired levels of efficacy in practice, with the reputation of some suffering through noted side-effects. As a result, there are significant commercial opportunities for more-efficacious and better-tolerated smoking-cessation agents, especially in prescription form. ( http://www.bharatbook.com/detail.asp?id=132311&rt=World-Smoking-Cessation-Drug-Market-2010-2025.html )

The report forecasts how the anti-smoking drug market will develop over the next 15 years. We predict that the launch of new smoking-cessation aids early this decade will answer some unmet needs currently limiting that pharma market segment. Besides extensive coverage of currently-marketed drugs, this report examines the most exciting products currently in development. We also include external opinions on the sector, gained thorough original unique surveys.

The report analyses current leading markets in North America, Europe and Asia in detail. A major contribution to the market during the next 15 years will come from emerging economies, led by India and China. Almost half of the world’s smokers live in those countries, with almost a third in China alone, reports suggest. At present, those national markets yield relatively low smoking-cessation revenues. However, It predicts that the emerging economies have a large potential for sales growth of smoking-cessation products. This report reveals how their sales revenues and market shares will expand during the forecast period.

The majority of smokers worldwide do not have full access to smoking-cessation therapies at present. The high economic and social costs associated with tobacco use are driving anti-smoking legislation and encouraging governmental spending on tobacco-dependency treatments. From 2010 to 2025, the implementation and expansion of tobacco-control policies – especially public smoking bans – will continue. Combined, those policies will help to increase the use of smoking-cessation products, agents still with a long way to go in their technological and commercial development, our report shows.

Highlights of the report include:

* Sales forecasts for the smoking-cessation drug market, leading therapy types and top products at global level
* Detailed examination of the smoking-cessation markets in the US, Canada, the UK, France, Germany, Sweden, Denmark, Japan, China and India, with sales forecasts
* Examination of strengths, weakness, opportunities and threats (SWOT factors) facing the industry and market
* Analysis of the R&D pipeline for smoking-cessation products.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=132311&rt=World-Smoking-Cessation-Drug-Market-2010-2025.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook